Clinical Trials Logo
  1. Home
  2. Neuropathic Pain
  3. NCT04184596
  4. Details
NCT04184596 Clinical Trial

Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)

Neuropathic Pain Clinical Trial

— DExPri  

Official title:
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04184596
Other study ID # VF/1014/1070
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 11, 2020
Est. completion date August 31, 2020

Study information
Verified date February 2021
Source LinkCare GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to identify and weight attributes of topic and systemic pain treatment options relevant from the patients' perspective with peripheral neuropathic pain. The study will use a discrete choice experimental design to reach its objective.

Recruitment information / eligibility
Status Completed
Enrollment 153
Est. completion date August 31, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with diagnosed peripheral neuropathic pain (pNP) as assessed by study sites Exclusion Criteria: - Patients with no sufficient knowledge in written or oral German as assessed by study sites

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Discrete Choice Experiment
An online-based Discrete-Choice Experiment (DCE) using a survey for stated treatment preferences and socio-demographics. Furthermore, the neuropathic pain component will be assessed in all patients with the Numeric Pain Rating Scale instrument.

Locations
Country Name City State
Germany LinkCare GmbH Stuttgart Baden-Württemberg
Germany Schmerz- und Palliativzentrum Rhein-Main Wiesbaden Hesse
Germany Schmerzpraxis Wiesbaden Wiesbaden Hesse

Sponsors (4)
Lead Sponsor Collaborator
LinkCare GmbH Grünenthal GmbH, Schmerz- und Palliativzentrum Rhein-Main Wiesbaden, Schmerzpraxis Wiesbaden

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Schubert T, Kern KU, Schneider S, Baron R. Oral or Topical Pain Therapy-How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain. Pain Pract. 2020 Dec 20. doi: 10.1111/papr.12989. [Epub ahead of print] — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Patient preferences for topical and systemic pain treatment attributes Utility values obtained via multinominal logit estimates from discrete choice experiment 20 minutes after survey start
Secondary Relevance of attributes attributed with topical and systemic pain treatment Derived from Likert scale 5 minutes after survey start
Secondary Marginal rate of substitution against pain reduction Derived from discrete choice experiment 20 minutes after survey start
See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Completed NCT05235191 - Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Not yet recruiting NCT05949554 - Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
Withdrawn NCT05052645 - Ear Acupuncture for Neuropathic Pain N/A
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Completed NCT02866396 - Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement
Completed NCT02824588 - Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain N/A
Active, not recruiting NCT02560545 - Cannabinoids Effects on the Pain Modulation System N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Completed NCT02099890 - The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Phase 3
Not yet recruiting NCT02246517 - The Effect of N2O on Chronic Neuropathic Pain Patients Phase 0
Completed NCT01946555 - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain N/A
Completed NCT01884662 - Virtual Walking for Neuropathic Pain in Spinal Cord Injury N/A
Completed NCT01718821 - Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients N/A
Completed NCT01669967 - The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin N/A
Completed NCT01201317 - A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy Phase 2
Completed NCT01207596 - Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain Phase 4

External Links